Bee Venom Acupuncture for the Treatment of Frozen Shoulder
Randomized Controlled Double Blind Study of Bee Venom Therapy on Adhesive Capsulitis of the Shoulder
1 other identifier
interventional
68
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of combined bee venom acupuncture (BVA) and physiotherapy (PT) on frozen shoulder, and whether if the effect of BVA is dose effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2010
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 1, 2012
CompletedFirst Posted
Study publicly available on registry
February 3, 2012
CompletedFebruary 3, 2012
February 1, 2012
6 months
February 1, 2012
February 1, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the Shoulder Pain and Disability Index (SPADI)
Changes from baseline in SPADI at 2, 4, 8, 12 weeks
Secondary Outcomes (2)
Visual Analogue Scale (VAS) for pain intensity
Changes from baseline in VAS at 2, 4, 8, 12 weeks
passive Range of Motion (pROM)
Changes from baseline in pROM at 2, 4, 8, 12 weeks
Study Arms (3)
BV1
EXPERIMENTAL1:10,000 bee venom (BV) acupuncture plus physiotherapy
BV2
EXPERIMENTAL1:30,000 bee venom (BV) acupuncture plus physiotherapy
NS
PLACEBO COMPARATORNormal saline injection plus physiotherapy
Interventions
after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11) * 1st visit : SC 0.4ml of 1:10,000 BV at 4 points (0.1ml for each points) * 2nd visit : SC 0.6ml of 1:10,000 BV at 6 points (0.1ml for each points) * 3rd visit : SC 0.8ml of 1:10,000 BV at 8 points (0.1ml for each points) * 4th to 16th visit : SC 1.0ml of 1:10,000 BV at 10 points (0.1ml for each points)
after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11) * 1st visit : SC 0.4ml of 1:30,000 BV at 4 points (0.1ml for each points) * 2nd visit : SC 0.6ml of 1:30,000 BV at 6 points (0.1ml for each points) * 3rd visit : SC 0.8ml of 1:30,000 BV at 8 points (0.1ml for each points) * 4th to 16th visit : SC 1.0ml of 1:30,000 BV at 10 points (0.1ml for each points)
after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11) * 1st visit : SC 0.4ml of normal saline at 4 points (0.1ml for each points) * 2nd visit : SC 0.6ml of normal saline at 6 points (0.1ml for each points) * 3rd visit : SC 0.8ml of normal saline at 8 points (0.1ml for each points) * 4th to 16th visit : SC 1.0ml of normal saline at 10 points (0.1ml for each points)
Physiotherapy treatment will be provided at each visit after bee venom or saline injection. * transcutaneous electrical nerve stimulation (TENS) for 15 minutes * transcutaneous infrared thermotherapy (TDP) for 15 minutes * manual physical therapy for 15 minutes * simple home exercise program
Eligibility Criteria
You may qualify if:
- Diagnosis of frozen shoulder by orthopedist
- Must have shoulder pain of more than VAS 5 over 1 month and under 12 months
- Marked limitation of active and/or passive motion range in one shoulder
You may not qualify if:
- history of major shoulder injury or surgery
- other musculoskeletal pain
- cervical neuropathy, paralysis, neurological disorder
- hypersensitivity reactions by bee venom skin test
- renal or hepatic disorders, hematologic diseases, cancer, mental disorders, inflammatory or infectious disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arthritis & Rheumatism Center, Kyung Hee University Hospital at Gangdong
Seoul, 134-727, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yonghyeon Baek, OMD, Ph.D
Kyung Hee University Hospital at Gangdong
- STUDY DIRECTOR
Byung-Kwan Seo, OMD, Ph.D
Kyung Hee University Hospital at Gangdong
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assisstant Professor
Study Record Dates
First Submitted
February 1, 2012
First Posted
February 3, 2012
Study Start
January 1, 2010
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
February 3, 2012
Record last verified: 2012-02